CLINICAL_TRIALS
trial_result
· 2017-08-16
Clinical Trial Update: Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease [Phase 2]
Summary
Phase 2 study evaluating photopheresis with UVADEX to prevent graft-versus-host disease after transplantation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt | Conditions: Graft-versus-Host Disease | Phase 2 | Status: COMPLETED